When you or someone you love is diagnosed, you’re immediately presented with decisions about treatment.
Often, it’s hard to know: Is this the right plan? Are there other options I should consider?
At Sagely Health, we help you understand the plan you’ve been given, assess whether it fits your unique situation, and uncover opportunities to improve your care. Sometimes that means affirming you’re on the right track. Other times, it means discovering something better.
Doctors often follow national NCCN guidelines to recommend safe, effective treatments.
Understanding your risk level makes it easier to know when to stick with the standard plan and when to dig deeper.
Your specific situation—such as genetics, test results, or cancer subtype—can point to better, more targeted options.
Even if your plan is right, it can be reassuring to know you’ve looked at every angle—and sometimes, you’ll discover a better path.
When you meet with your oncologist, they’re likely drawing from something called the NCCN guidelines—national standards reviewed and updated by cancer experts several times a year. These guidelines help ensure that patients across the country get safe, evidence-based care.
That’s a good thing. But there’s a catch.
Not all oncologists keep up with the newest recommendations. Some have limited time to interpret complex updates. And not every doctor personalizes the plan for your exact diagnosis, stage, or biomarkers. And not all oncologists are involved in clinical trials which could be a better option for you.
In other words: you may be getting good care—but it’s worth checking if you could be getting the best.
Even with the same diagnosis, two patients may need two very different plans.
— Jason Sager, MD
If the chance of cure isn’t 80% or higher, we consider that high risk—and that’s when we start looking for something better. That usually means clinical trials.
One of the first questions we help patients answer is:
“Am I considered high risk or low risk?”
The cancer has a high likelihood (80% or more) of being cured with the current standard plan.
There’s a lower chance of cure—or a higher risk of recurrence—without additional steps.
Knowing your risk level helps shape your next move:
Often do well with the standard of care, especially if it’s up-to-date and thoughtfully applied.
Will benefit from additional testing, personalized strategies, or clinical trial options.
Either way, our goal is to make sure you have clarity—and confidence—about the plan ahead.
Most treatment plans follow well-established standards—but in some cases, a clinical trial might offer something better.
If your cancer is high risk, or if the standard approach isn’t likely to achieve long-term success, clinical trials can sometimes offer newer, more targeted therapies not yet available everywhere
We help you figure out:
You don’t have to navigate this alone—we include trial options when reviewing your plan, whenever they’re relevant.
Learn more about clinical trials or ask us during your consult.
If you ask for a second opinion and you're sent to a different oncologist who also doesn't have a clinical trial to offer, you will likely to hear the same response.
— Jason Sager, MD
There’s no wrong time to get a second look. But here are moments when it can be especially helpful:
We analyze your treatment plan based on your diagnosis, stage, and test results—checking it against national guidelines and current research.
We flag anything that might’ve been overlooked—like missing tests, newer options, or better timing of treatments.
If improvements are possible—like a clinical trial or updated approach—we explain your options in a report you can share with your doctor.
Contact us if you have questions not covered here.
Ready to take diagnostics a step further? Our service includes detailed record review, research, and 1-hour consultation with Dr. Sager.
Explore the services we provide with each consultation:
Get started today—get professional, expert guidance toward the best available treatment, personalized for you.
